Phase II Study of Bevacizumab in Combination with Docetaxel and Capecitabine for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer

被引：0

作者：

Musolino, A.

Bisagni, G.

De Matteis, A.

Nuzzo, F.

Ardizzoni, A.

Crino, L.

Gamucci, T.

Passalacqua, R.

Gnoni, R.

Boni, C.

机构：

[1] Univ Hosp Parma, Parma, Italy

[2] Arcispedale S Maria Nuova, Reggio Emilia, Italy

[3] Fdn G Pascale, Ist Nazl Tumori, Naples, Italy

[4] Osped S Maria Misericordia, Perugia, Italy

[5] Osped Santissima Trinita, Frosinone, Italy

[6] Azienda Ist Osp Cremona, Cremona, Italy

[7] Italian Oncol Grp Clin Res GOIRC, Parma, Italy

来源：

关键词：

D O I：

10.1158/0008-5472.SABCS10-P2-17-01

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2-17-01

引用

页数：1